Micafungin indications and usage: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) (Created page with "__NOTOC__ {{Micafungin}} {{CMG}}; {{AE}} {{AZ}} ==Indications and Usage== Mycamine® is indicated in adult and pediatric patients 4 months and older for: * '''Candidemia'''...") |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 9: | Line 9: | ||
* '''Candidemia''' | * '''Candidemia''' | ||
*'''Acute Disseminated Candidiasis''' *'''Candida Peritonitis''' and '''Abscesses''' | *'''Acute Disseminated Candidiasis''' | ||
*'''Candida Peritonitis''' and '''Abscesses''' | |||
Mycamine has '''not been''' adequately studied in patients with [[endocarditis]], [[osteomyelitis]] and [[meningitis]] due to [[Candida]] infections. | Mycamine has '''not been''' adequately studied in patients with [[endocarditis]], [[osteomyelitis]] and [[meningitis]] due to [[Candida]] infections. | ||
Revision as of 10:34, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Indications and Usage
Mycamine® is indicated in adult and pediatric patients 4 months and older for:
- Candidemia
- Acute Disseminated Candidiasis
- Candida Peritonitis and Abscesses
Mycamine has not been adequately studied in patients with endocarditis, osteomyelitis and meningitis due to Candida infections.
Treatment of Patients with Esophageal Candidiasis
Prophylaxis of Candida Infections in Patients Undergoing Hematopoietic Stem Cell Transplantation
NOTE: The efficacy of Mycamine against infections caused by fungi other than Candida has not been established.[1]
References
Adapted from the FDA Package Insert.